Extreme Short Stature and Severe Neurological Impairment in a 17-Year-Old Male With Untreated Combined Pituitary Hormone Deficiency Due to POU1F1 Mutation

@KatariinaMaki @HannesLohi Has anyone shown interest in dog growth hormone treatment as a model for human POU1F1 dwarfism? E.g., here: 17-year-old male of height 81.7 cm, −9.3 SD; GH therapy initiated at 19 years of age, resulting in 42 cm linear growth, t

New Research: Extreme Short Stature and Severe Neurological Impairment in a 17-Year-Old Male With Untreated Combined Pituitary Hormone Deficiency Due to POU1F1 Mutation: Background:POU1F1 is an essential transcription factor for the… https://t.co/aYMZWlGPk